Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Cancer Chemother Pharmacol. 2012 May 24;70(1):83–94. doi: 10.1007/s00280-012-1878-y

Table 2.

Parameter estimates from AMD population pharmacokinetic models

Historical model Base model Contamination model
Parameter (Point estimate, % RSE)
 CL, L/h/70 kg 9.99 (11.2) 9.82 (12.2) 11 (9.36)
 V1, L/70 kg 3.56 (39.3) 3.17 (61.8) 5.79 (18.3)
 V2, L/70 kg 16.1 (80.7) 16.1 (116) 24.2 (69.4)
 V3, L/70 kg 367 (19.7) 367 (28.1) 490 (8.29)
 Q2, L/h/70 kg 11.4 (58.8) 10.9 (93.6) 17.7 (38)
 Q3, L/h/70 kg 25.2 (23.3) 24.1 (35.1) 42.8 (13.6)
 CL, Q2, Q3 ~ WT/70 power 3/4 fixed 3/4 fixed 3/4 fixed
 V1, V2, V3 ~ WT/70 power 1 fixed 1 fixed 1 fixed
 V1 ~ AGE/8.8 power - -0.329 (30.4) -0.448 (26.6)
 CTM - - 0.193 (17.9)
 Ke, h−1 - - 0.0932 (18.1)
IIV (% CV, % RSE)
ωCL2 40.4 (56.3) 39.9 (60.8) 48.4 (28.1)
ωV12 49 (36.2) 41.6 (54.5) 24.6 (64.2)
ωCTM2 - - 127 (40.9)
 COVCL,VI -0.057a -0.0412a -0.0507a
 COVCL,CTM - - -0.198a
 COVV1,CTM - - -0.0601a
Residual variance (% CV, % RSE)
σprop2 24.7 (34.5) 24.6 (33.2) 19.6 (27)

IIV inter-individual variability, CL clearance, COVCL,Vl covariance between random effect of CL and V, CTM contamination factor, CV coefficient of variation, Ke rate constant for change in contamination factor, Q2 and Q3 inter-compartmental clearance, RSE relative standard error of the estimate, VI volume of central compartment, V2 and V3 volume of peripheral compartment; WT body weight, ωCL2 and ωV12 variances of random effect of CL and V1, respectively, σprop2 proportional residual error model

a

Point estimate